Determinación de la toxicidad de Pleurotus ostreatus, Pleurotus pulmonarius y Paxillus involutus sobre Artemia salina

Antkowiak, 2003, A new phenolic metabolite, involutone, isolated from the mushroom Paxillus involutus, Can J Chem, 81, 118, 10.1139/v02-194 Brizuela, 1998, Basidiomicetos: nueva fuente de metabolitos secundarios, Rev Iberoam Micol, 15, 69 Colegate, 2000 Diaz, 2001, Mercado internacional de hongos exóticos Habtemariam, 1996, Cytotoxicity of extracts from the mushroom Paxillus involutus, Toxicon, 34, 711, 10.1016/0041-0101(96)00024-4 Iturriaga, 1992, Papel de los hongos en el Amazonas, 72 Martínez-Carrera, 2002, Current development of mushroom biotechnology in Latin America, Micol Apl Int, 14, 61 Miles, 1999 Nieminen, 1997, Short-term toxicity study of Paxillus involutus in the rat, Food Cosmet Toxicol, 15, 445, 10.1016/S0015-6264(77)80011-4 Robbins, 1947, Antibiotic substances from basidiomycetes I. Pleurotus griseus, Botany, 33, 171 Rodríguez-Valencia, 2001, Cultive hongos comestibles en pulpa de café, Avances técnicos Cenicafé, 285, 1 Salama, 1996, Fito y bioanálisis de algunas plantas utilizadas en la medicina popular con possible actividad farmacológica, Rev Col Cien Quim Farm, 25, 44 Smith J, Rowan N, Sullivan R. Medicinal mushrooms: their therapeutic properties and current medical usage with special emphasis on cancer treatments. Special report commissioned by Cancer Research U.K. http://sci.cancerresearchuk.org/labs/med_mush/med_mush.html. 2002. Vokáč, 1998, New ergostane type ecdysteroid constituents of mushroom Paxillus atrotomentosus, Tetrahedron, 54, 1657, 10.1016/S0040-4020(97)10373-8 Wasser, 1999, Medicinal properties of substances ocurring in higher basidiomycetes mushrooms: current perspectives, Int J Med Mush, 1, 31, 10.1615/IntJMedMushrooms.v1.i1.30 Zhuang, 1993, Antitumor protein-containing polysaccharides from a Chinese mushroom Fengweigu or Houbitake, Pleurotus sajor-caju (Fr.) Sings, Biosci Biotech Biochem, 57, 901, 10.1271/bbb.57.901